|
FLGT | Fulgent Genetics, Inc. |
|
|
FLGT | Fulgent Genetics, Inc. |
| Services-Medical Laboratories |
| Book value per $ invested | $ 2.06 |
| Leverage | 8.01% |
| Market Cap | $ 550.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -160.8m |
| Margin | -58.24% |
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California.